Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality

Menopause

Volumn 22, Issue 9, 2015, Pages 976-983

  Mikkola, Tomi S ^a,b,f   Tuomikoski, Pauliina ^a   Lyytinen, Heli ^a   Korhonen, Pasi ^c   Hoti, Fabian ^c   Vattulainen, Pia ^c   Gissler, Mika ^d,e   Ylikorkala, Olavi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c EPID Research Oy   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cardiovascular disease; Coronary heart disease; Estrogen; Menopause; Stroke

Indexed keywords

ESTRADIOL; GESTAGEN; NORETHISTERONE ACETATE;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; ENVIRONMENTAL EXPOSURE; FEMALE; FINLAND; FOLLOW UP; HEART INFARCTION; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTMENOPAUSE; REIMBURSEMENT; RISK FACTOR; RISK REDUCTION; AGE; CARDIOVASCULAR DISEASES; EPIDEMIOLOGY; ESTROGEN THERAPY; MORTALITY; REGISTER; STROKE;

AGE FACTORS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FINLAND; HUMANS; MIDDLE AGED; POSTMENOPAUSE; REGISTRIES; RISK FACTORS; STROKE;

EID: 84932180515     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000450     Document Type: Article

References (27)

1. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-1037
2. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151: 75-78
3. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769-1775
4. Panico S, Galasso R, Celentano E, et al. Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations. Am J Public Health 2000; 90: 1397-1402
5. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350: 1047-1059
6. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992; 117: 1038-1041
7. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333
8. Smith NL, Blondon M, Wiggins KL, et al. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA Intern Med 2014; 174: 25-31
9. Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012; 345: e6409
10. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308: 1583-1587
11. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol 2009; 113: 65-73
12. Sitruk-Ware R. The levonorgestrel intrauterine system for use in peri-And postmenopausal women. Contraception 2007; 75: S155-S160
13. Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133: 933-941
14. Vartiainen E, Laatikainen T, Peltonen M, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 504-518
15. Tuomikoski P, Lyytinen H, Korhonen P, et al. Coronary heart disease mortality and hormone therapy before and after the Womens Health Initiative. Obstet Gynecol 2014; 124: 947-953
16. Topo P, Luoto R, Hemminki E, Uutela A. Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 1999; 32: 141-145
17. Lehto HR, Lehto S, Havulinna AS, et al. Sex differences in short-And long-Term case-fatality of myocardial infarction. Eur J Epidemiol 2011; 26: 851-861
18. Winell K, Paakkonen R, Pietilä A, et al. Prognosis of ischaemic stroke is improving similarly in patients with type 2 diabetes as in nondiabetic patients in Finland. Int J Stroke 2011; 6: 295-301
19. Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005; 12: 132-137
20. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002; 3: 605-619
21. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Womens Health Initiative randomized trials. JAMA 2013; 310: 1353-1368
22. Gu H, Zhao X, Zhao X, Yang Y, Lv X. Risk of stroke in healthy postmenopausal women during and after hormone therapy: a metaanalysis. Menopause 2014; 21: 1204-1210
23. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Womens Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-1712
24. Causes of death in 2012. Statistics Finland. Available at: http://www.stat.fi/til/ksyyt/2012/ksyyt-2012-2013-12-30-kat-001-en.html. Accessed December 13, 2014
25. Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427
26. Sarkeala T, Heinavaara S, Anttila A. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Int J Cancer 2008; 122: 614-619
27. Jaakkola S, Lyytinen H, Pukkala E, Ylikorkala O. Endometrial cancer in postmenopausal women using estradiol-progestin therapy. Obstet Gynecol 2009; 114: 1197-1204